by Robert Hayes Posted on July 27, 2024July 27, 2024 BUSINESS BRIEF: Wilmington’s Charles River Labs & Autobahn Labs Announce Collaborative Program To Accelerate Academic Drug Discovery Read More
by Robert Hayes Posted on June 12, 2024June 12, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Awarded Grant From Foundation For Chemistry Research & Initiatives Read More
by Robert Hayes Posted on April 23, 2024April 23, 2024 BUSINESS BRIEF: Wilmington’s Charles River Labs Achieves 100% Renewable Electricity Usage Globally Read More
by Robert Hayes Posted on April 18, 2024April 18, 2024 PETA Alleges Wilmington’s Charles River Labs Misled Shareholders On Sourcing Of Monkeys, Urges SEC To Investigate Read More
by Robert Hayes Posted on April 16, 2024April 17, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Launches Alternative Methods Advancement Project To Reduce Reliance on Animal Testing Read More
by Robert Hayes Posted on April 9, 2024April 10, 2024 BUSINESS BRIEF: Wilmington’s Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics Read More
by Robert Hayes Posted on April 5, 2024April 5, 2024 BUSINESS BRIEF: Wilmington’s Charles River & Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on January 29, 2024January 29, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Adds Reshema Kemps-Polanco To Board Of Directors Read More
by Robert Hayes Posted on July 26, 2023July 26, 2023 OBITUARY: Kathleen A. Murray, D.V.M, 68 Read More
Wilmington Apple 
You must be logged in to post a comment.